Alpha 2.0
Login Register
» Articles » PMID: 6721472

In Vitro Activity of Ticarcillin Plus Clavulanic Acid Against 632 Clinical Isolates

Overview
Journal Antimicrob Agents Chemother
Publisher American Society for Microbiology
Specialty Pharmacology
Date 1984 Mar 1
PMID 6721472
Citations 21
Authors
P C Fuchs
A L Barry
C Thornsberry
R N Jones
Affiliations
Soon will be listed here.
Abstract

A total of 632 clinical bacterial isolates were tested for susceptibility to twofold dilutions of ticarcillin alone and in combination with 1, 2, and 4 micrograms of clavulanic acid (CA) (Timentin) per ml by a reference microdilution method. With the addition of CA, ticarcillin MICs were reduced eightfold or greater with 54 of 59 (92%) strains of the family Enterobacteriaceae with ticarcillin MICs of greater than or equal to 64 micrograms/ml. The inhibitory effect of CA on pseudomonads was minimal. Ticarcillin MICs for beta-lactamase-producing Haemophilus influenzae, Neisseria gonorrhoeae, and most Staphylococcus aureus were reduced to less than or equal to 0.5 micrograms/ml when CA was added. For dilution susceptibility testing of ticarcillin-clavulanic acid, dilutions of ticarcillin combined with 2 micrograms of CA per ml is suggested.

Citing Articles

Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records data.

Madaras-Kelly K, Jones M, Remington R, Caplinger C, Huttner B, Samore M BMC Infect Dis. 2015; 15:197.

PMID: 25927970 PMC: 4418054. DOI: 10.1186/s12879-015-0933-9.

Three decades of beta-lactamase inhibitors.

Drawz S, Bonomo R Clin Microbiol Rev. 2010; 23(1):160-201.

PMID: 20065329 PMC: 2806661. DOI: 10.1128/CMR.00037-09.

Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases.

Sabbagh Y, Theriault E, Sanschagrin F, Voyer N, Palzkill T, Levesque R Antimicrob Agents Chemother. 1998; 42(9):2319-25.

PMID: 9736556 PMC: 105826. DOI: 10.1128/AAC.42.9.2319.

Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.

Pfaller M, Barry A, Fuchs P, Gerlach E, Hardy D, McLaughlin J Eur J Clin Microbiol Infect Dis. 1993; 12(3):200-5.

PMID: 8389705 DOI: 10.1007/BF01967112.

Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.

Fuchs P, Jones R, Barry A, Thornsberry C J Clin Microbiol. 1984; 19(4):555-7.

PMID: 6715524 PMC: 271119. DOI: 10.1128/jcm.19.4.555-557.1984.

References
1.
Reading C, Cole M . Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977; 11(5):852-7. PMC: 352086. DOI: 10.1128/AAC.11.5.852. View
2.
Fuchs P, Thornsberry C, Barry A, Gavan T, Gerlach E, Jones R . Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins. J Antibiot (Tokyo). 1977; 30(12):1098-106. DOI: 10.7164/antibiotics.30.1098. View
3.
Paisley J, Washington 2nd J . Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli. Antimicrob Agents Chemother. 1978; 14(2):224-7. PMC: 352437. DOI: 10.1128/AAC.14.2.224. View
4.
Neu H, Fu K . Clavulanic acid, a novel inhibitor of beta-lactamases. Antimicrob Agents Chemother. 1978; 14(5):650-5. PMC: 352529. DOI: 10.1128/AAC.14.5.650. View
5.
Thornsberry C, Baker C, Jones R . In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains. J Antimicrob Chemother. 1979; 5(2):137-42. DOI: 10.1093/jac/5.2.137. View